Literature DB >> 20297945

Disulfiram in severe alcoholism--an open controlled study.

Jakob Ulrichsen1, Mogens Kai Nielsen, Michelle Ulrichsen.   

Abstract

BACKGROUND: Disulfiram is used to a great extent in Denmark to treat alcoholism but the evidence is limited. AIM: To study the effect of supervised disulfiram treatment in alcohol dependence. Subjects were recruited from a psychiatric emergency ward following alcohol withdrawal treatment.
METHODS: A total of n=39 patients were openly randomized to either disulfiram 800 mg twice a week for 26 weeks (n=19) or no disulfiram (n=20). All patients were also treated with cognitive behavioural therapy (CBT) in groups.
RESULTS: The rate of abstinence was 20% and 26% in the control and disulfiram group, respectively. This difference was not statistically significant (NS). A trend towards increased mean time to first drink was found in the disulfiram group (96 vs. 76 days in the control group, NS), while fewer patients in this group completed CBT group therapy (41% vs. 67% in the control group, NS). Alcohol-free days were 100 days in both groups (NS).
CONCLUSION: Supervised disulfiram administration did not have any major impact on the treatment outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20297945     DOI: 10.3109/08039481003686180

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  6 in total

Review 1.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

Review 2.  Alcohol Use Disorder: Neurobiology and Therapeutics.

Authors:  Waisley Yang; Rohit Singla; Oshin Maheshwari; Christine J Fontaine; Joana Gil-Mohapel
Journal:  Biomedicines       Date:  2022-05-21

3.  Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.

Authors:  Michael P Bogenschutz; Snehal Bhatt; Juliane Bohan; Bellelizabeth Foster; Paul Romo; Claire E Wilcox; J Scott Tonigan
Journal:  Am J Drug Alcohol Abuse       Date:  2016-05-16       Impact factor: 3.829

Review 4.  Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Authors:  Julia M A Sinclair; Sophia E Chambers; Celia J Shiles; David S Baldwin
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

5.  Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.

Authors:  Marilyn D Skinner; Pierre Lahmek; Héloïse Pham; Henri-Jean Aubin
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

6.  Primary Reason for Drinking Among Current, Former, and Never Flushing College Students.

Authors:  Sarah Soyeon Oh; Yeong Jun Ju; San Lee; Eun-Cheol Park
Journal:  Int J Environ Res Public Health       Date:  2019-01-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.